2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry.
Journal
ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073
Informations de publication
Date de publication:
09 Jul 2020
09 Jul 2020
Historique:
received:
07
04
2020
accepted:
08
06
2020
entrez:
18
7
2020
pubmed:
18
7
2020
medline:
18
7
2020
Statut:
epublish
Résumé
To obtain effective eradication of numerous infectious diseases such as tuberculosis, it is important to supply the medicinal chemistry arsenal with novel chemical agents. Isosterism and bioisosterism are widely known concepts in the field of early drug discovery, and in several cases, rational isosteric replacements have contributed to improved efficacy and physicochemical characteristics throughout the hit-to-lead optimization process. However, sometimes the synthesis of isosteres might not be as straightforward as that of the parent compounds, and therefore, novel synthetic strategies must be elaborated. In this regard, we herein report the evaluation of a series of N-substituted 4-phenyl-2-aminooxazoles that, despite being isosteres of a widely used nucleus such as the 2-aminothiazole, have been only seldom explored. After elaboration of a convenient synthetic strategy, a small set of 2-aminothiazoles and their 2-aminooxazole counterparts were compared with regard to antitubercular activity and physicochemical characteristics.
Identifiants
pubmed: 32676151
doi: 10.1021/acsmedchemlett.0c00173
pmc: PMC7357219
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1435-1441Informations de copyright
Copyright © 2020 American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
J Med Chem. 2017 Aug 24;60(16):7108-7122
pubmed: 28749666
Chem Rev. 1996 Dec 19;96(8):3147-3176
pubmed: 11848856
J Pharm Sci. 2001 Nov;90(11):1838-58
pubmed: 11745742
Org Lett. 2012 Mar 16;14(6):1432-5
pubmed: 22394197
Angew Chem Int Ed Engl. 2017 Aug 21;56(35):10569-10572
pubmed: 28605135
Lancet Respir Med. 2017 Mar 15;:
pubmed: 28344011
Int J Mol Sci. 2019 Nov 21;20(23):
pubmed: 31766441
J Med Chem. 2010 Apr 8;53(7):2719-40
pubmed: 20131845
Future Microbiol. 2018 Sep;13:1383-1402
pubmed: 30259757
J Med Chem. 2015 Feb 12;58(3):1205-14
pubmed: 25559643
Eur J Med Chem. 2014 Jan 24;72:26-34
pubmed: 24333612
Ultrason Sonochem. 2013 Jan;20(1):287-93
pubmed: 22784641
ACS Chem Biol. 2018 Jan 19;13(1):36-44
pubmed: 29202222
Drug Metab Dispos. 1999 Nov;27(11):1350-9
pubmed: 10534321
Euro Surveill. 2007 May 17;12(5):E070517.1
pubmed: 17868596
Eur J Med Chem. 2015 Jul 15;100:44-9
pubmed: 26071857
Curr Opin Pharmacol. 2018 Oct;42:81-94
pubmed: 30144650
J Med Chem. 2015 Aug 13;58(15):5842-53
pubmed: 26197353
Antibiotics (Basel). 2020 Apr 28;9(5):
pubmed: 32353943
J Am Chem Soc. 2018 Apr 4;140(13):4721-4725
pubmed: 29529363